Showing 1 - 4 results of 4 for search 'Barbara A Jennings', query time: 0.02s Refine Results
  1. 1
    Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma.

    Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma. by Ryan Cardenas, Peter Prinsley, Carl Philpott, Mahmood F Bhutta, Emma Wilson, Daniel S Brewer, Barbara A Jennings

    Published 2023-01-01
    Get full text
    Article
  2. 2
    Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma

    Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma by Ryan Cardenas, Peter Prinsley, Carl Philpott, Mahmood F. Bhutta, Emma Wilson, Daniel S. Brewer, Barbara A. Jennings

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines.

    Evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines. by Barbara A Jennings, Yoon K Loke, Jane Skinner, Melanie Keane, Gavin S Chu, Richard Turner, Daniel Epurescu, Ann Barrett, Gavin Willis

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Correction: evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines.

    Correction: evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines. by Barbara A Jennings, Yoon K Loke, Jane Skinner, Melanie Keane, Gavin S Chu, Richard Turner, Daniel Epurescu, Ann Barrett, Gavin Willis

    Published 2015-01-01
    Get full text
    Article

Search Tools: